SIREN : 530959170
3BIOTECH is a French company founded 15 years ago, specialized in the sector Activités spécialisées, scientifiques et techniques diverses. Based in PARIS (75008), this company of category PME shows in 2024 a net income positive of 51 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 |
|---|---|
| Revenue | N/C |
| Net income | 50 790 € |
| EBITDA | N/C |
| Net margin | N/C |
In 2024, 3BIOTECH generates positive net income of 51 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
50 790 €
The debt ratio (= Financial debt / Equity x 100) stands at 56%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
56.289%
55.78%
53.9%
In 2024, the debt ratio of 3BIOTECH (56.29) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of 3BIOTECH (55.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
The liquidity ratio (= Current assets / Current liabilities) stands at 939.51. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
939.511
In 2024, the liquidity ratio of 3BIOTECH (939.51) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Based on 98 transactions of similar company sales
(all years),
the value of 3BIOTECH is estimated at
246 511 €
(range 49 633€ - 414 667€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 98 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare 3BIOTECH with other companies in the same sector:
Voir toutes les statistiques du secteur Activités spécialisées, scientifiques et techniques diverses
The revenue of 3BIOTECH is not publicly disclosed (confidential accounts filed with INPI).
Yes, 3BIOTECH generated a net profit of 51 k€ in 2024.
The headquarters of 3BIOTECH is located in PARIS (75008), in the department Paris.
The tax return of 3BIOTECH is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
3BIOTECH operates in the sector Activités spécialisées, scientifiques et techniques diverses (NAF code 74.90B). See the 'Sector positioning' section above to compare the company with its competitors.